Trials / Completed
CompletedNCT01214434
Promiseb Topical Cream for Cradle Cap
A Double Blind, Placebo-Controlled, Pilot Study to Estimate the Efficacy and Tolerability of Twice Daily Promiseb Topical Cream in Pediatric Subjects With Cradle Cap (Seborrheic Dermatitis)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Promius Pharma, LLC · Industry
- Sex
- All
- Age
- 30 Days
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of Promiseb Topical Cream in cradle cap.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Promiseb Topical Cream | topical non steroidal cream, twice daily |
| OTHER | Bland emollient | Eucerin cream twice daily |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2011-06-01
- Completion
- 2011-06-01
- First posted
- 2010-10-05
- Last updated
- 2017-03-07
- Results posted
- 2013-11-20
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01214434. Inclusion in this directory is not an endorsement.